| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7030104 |
Topical oestroprogestational compositions with a systemic effect |
Apr. 18, 2006 |
| 7026306 |
Steroidal quinols and their use for antioxidant therapy |
Apr. 11, 2006 |
| 7018992 |
Hormone composition |
Mar. 28, 2006 |
| 7018993 |
Antiandrogenic agent |
Mar. 28, 2006 |
| 6989378 |
Testosterone derivative |
Jan. 24, 2006 |
| 6969708 |
Process for the preparation of a high purity composition comprising (7.alpha., 17.alpha.)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
Nov. 29, 2005 |
| 6964954 |
Use of DHEA derivatives on keratinous substances |
Nov. 15, 2005 |
| 6964953 |
Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
Nov. 15, 2005 |
| 6962908 |
Oral pharmaceutical products containing 17 .beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Nov. 8, 2005 |
| 6953586 |
Growth promoting pharmaceutical implant |
Oct. 11, 2005 |
| 6949533 |
6,7-Oxygenated steroids and uses related thereto |
Sep. 27, 2005 |
| 6930125 |
Airway alkalinization as a therapy for airway diseases |
Aug. 16, 2005 |
| 6924274 |
Use of .DELTA.5-androstene-3.beta.-ol-7,17-dione in the treatment of lupus erythematosus |
Aug. 2, 2005 |
| 6906049 |
Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
Jun. 14, 2005 |
| 6903084 |
Steroid sulphatase inhibitors |
Jun. 7, 2005 |
| 6900239 |
Tumor chemopotentiation using isocoumarin derivatives |
May. 31, 2005 |
| 6884793 |
Combination preparation for contraception based on natural estrogens |
Apr. 26, 2005 |
| 6884794 |
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
Apr. 26, 2005 |
| 6881728 |
14-.beta., 17-.alpha.-hydroxymethylandrostane derivatives as androgens |
Apr. 19, 2005 |
| 6858597 |
Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
Feb. 22, 2005 |
| 6852710 |
2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
Feb. 8, 2005 |
| 6846812 |
7-Oxo-DHEA compounds for treating keratinous conditions/afflictions |
Jan. 25, 2005 |
| 6844320 |
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
Jan. 18, 2005 |
| 6844334 |
(3) and (6) substitued estrogenic compounds |
Jan. 18, 2005 |
| 6844333 |
Method of treating atherosclerosis |
Jan. 18, 2005 |
| 6841548 |
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
Jan. 11, 2005 |
| 6831073 |
Hormonal composition consisting of an oestrogen compound and of a progestational compound |
Dec. 14, 2004 |
| 6821961 |
Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents |
Nov. 23, 2004 |
| 6818636 |
B-ring estratrienes |
Nov. 16, 2004 |
| 6803060 |
Composition to boost libido |
Oct. 12, 2004 |
| 6797282 |
Combination progestin oral contraceptive regimen |
Sep. 28, 2004 |
| 6794374 |
Use of .DELTA.5-androstene-3.beta.-OL7,17-dione in the treatment of arthritis |
Sep. 21, 2004 |
| 6787529 |
Topical composition |
Sep. 7, 2004 |
| 6787531 |
Pharmaceutical composition for use as a contraceptive |
Sep. 7, 2004 |
| 6780854 |
Orally active androgens |
Aug. 24, 2004 |
| 6777389 |
Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides |
Aug. 17, 2004 |
| 6774122 |
Formulation |
Aug. 10, 2004 |
| 6767902 |
Androgen as a male contraceptive and non-contraceptive androgen replacement |
Jul. 27, 2004 |
| 6765001 |
Compositions and methods for enhancing corticosteroid delivery |
Jul. 20, 2004 |
| 6759408 |
Combination regimens using progesterone receptor modulators |
Jul. 6, 2004 |
| 6759400 |
Meiosis regulating compounds |
Jul. 6, 2004 |
| 6756366 |
Orally active androgens |
Jun. 29, 2004 |
| 6753326 |
14, 15-..alpha..-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
Jun. 22, 2004 |
| 6753013 |
Pharmaceutical composition |
Jun. 22, 2004 |
| 6740646 |
Bioavailable prodrugs of androgenic steroids and related method |
May. 25, 2004 |
| 6723715 |
14, 15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
Apr. 20, 2004 |
| 6710039 |
Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharamceutical compositions containing these compounds |
Mar. 23, 2004 |
| 6706700 |
14.beta.,15.beta.-methylene-17.alpha.-hydroxymethyl-androgens |
Mar. 16, 2004 |
| 6706701 |
6, 7-oxygenated steroids and uses related thereto |
Mar. 16, 2004 |
| 6677325 |
Steroid sulphatase inhibitors |
Jan. 13, 2004 |
|
|
|
